Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH Blockade and Metabolism During Fasting in Obese Subjects
NCT02500095Completed
- Sponsor
- Aarhus University
- Start
- Jul 2015
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of pegvisomant in insulin resistance (IR), sponsored by Aarhus University. Primary endpoint: Change in phosphorylation of intracellular target proteins and mRNA expression of target genes in muscle and fat tissue at 8 weeks. Started Jul 2015; status: completed.
02
Drugs
pegvisomant
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02500095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500095.